Advertisement

Reactions Weekly

, Volume 1777, Issue 1, pp 104–104 | Cite as

Durvalumab/ipilimumab/nivolumab

Pneumonitis: 14 case reports
Case report
  • 18 Downloads

Reference

  1. Suresh K, et al. Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors. Journal of Thoracic Oncology 13: 1930-1939, No. 12, Dec 2018. Available from: URL: http://doi.org/10.1016/j.jtho.2018.08.2035 - USACrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations